Understand the source comparison
How to Use Peptides for Cancer Research Peptides: Dosing, Delivery, and Experimental Design Comparison
Different cancer research models require distinct dosing routes, peptide formulations, and timing protocols. Here's how they compare: In Vitro Cell Culture (2D/3D) Direct media addition 1–100 µM depending on target Bacteriostatic water or DMSO <10% Stable 7–14
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different cancer research models require distinct dosing routes, peptide formulations, and timing protocols. Here's how they compare:
- In Vitro Cell Culture (2D/3D)
- Direct media addition
- 1–100 µM depending on target
- Bacteriostatic water or DMSO <10%
- Stable 7–14 days at 4°C in culture media
- Best for receptor binding assays and initial cytotoxicity screens. Fast turnaround, easy dose titration
- Xenograft Mouse Models
- Subcutaneous or intraperitoneal injection
- 0.5–5 mg/kg body weight, daily or q48h
- Sterile saline or PBS pH 7.4
- Single-use aliquots only. Discard after 24h at 4°C
- Gold standard for pharmacokinetics and tumor suppression efficacy. Requires sterile technique
- Patient-Derived Organoids
- Direct organoid media perfusion
- 10–500 nM depending on pathway
- Cell culture–grade bacteriostatic water
- Stable 5–7 days in organoid media at 37°C
- Closest to human tumor microenvironment. Ideal for personalised therapy screening
- Ex Vivo Tumor Slice Culture
- Direct application to tissue slice
- 1–50 µM applied topically
- Sterile PBS or HBSS
- Use within 6 hours of reconstitution
- Maintains tumor architecture and stromal interactions. Limited by tissue viability window
- The choice of delivery route affects peptide bioavailability dramatically. Subcutaneous injection in mouse models achieves 60–80% bioavailability, but intraperitoneal injection can exceed 90% for hydrophilic peptides. In cell culture, peptides added directly to media face potential degradation by serum proteases. Using serum-free media during peptide incubation periods extends active exposure time.